Bristol-Myers Squibb Says Cancer Drug Combination Fails Late-Stage Trial Bristol-Myers Squibb Says Cancer Drug Combination Fails Late-Stage Trial

Bristol-Myers Squibb Co said on Monday a combination of two of its cancer drugs, being tested as a maintenance therapy, did not meet the main goal of extending the lives of lung cancer patients in a late-stage trial.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news